Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2020
Jan. 31, 2020
Current assets:    
Cash, cash equivalents and restricted cash $ 5,124 $ 9,297
Marketable securities 1,034 3,835
Accounts receivable, net of allowance for doubtful accounts of $903 and $947 at October 31, 2020 and January 31, 2020, respectively 5,259 12,127
Unbilled receivables 11,509 14,279
Prepaid expenses and other current assets 4,755 5,112
Total current assets 27,681 44,650
Property and equipment, net 641 554
Operating lease right-of-use assets 5,231 4,860
Marketable securities, long-term   782
Intangible assets, net 1,528 2,300
Goodwill 10,249 9,775
Unbilled receivables, long-term 7,527 9,031
Other assets 756 938
Total assets 53,613 72,890
Current liabilities:    
Accounts payable 2,765 4,007
Accrued expenses 4,628 7,986
Deferred revenue 3,180 5,041
Promissory note 1,475  
Total current liabilities 12,048 17,034
Deferred revenue, long-term 643 1,140
Operating lease liabilities, long-term 4,299 4,348
Taxes payable, long-term 328 436
Promissory note, long-term 938  
Deferred tax liabilities, long-term 246  
Total liabilities 18,502 22,958
Commitments and contingencies (Note 6)
Stockholders' equity:    
Common stock, $0.01 par value; 100,000,000 shares authorized at October 31, 2020 and January 31, 2020; 37,727,987 shares issued and 37,556,067 shares outstanding at October 31, 2020; 37,303,952 shares issued and 37,163,462 outstanding at January 31, 2020 377 373
Additional paid-in capital 246,254 245,067
Treasury stock, at cost; 171,920 shares at October 31, 2020 and 140,490 shares at January 31, 2020 (227) (147)
Accumulated other comprehensive loss (676) (2,137)
Accumulated deficit (210,617) (193,224)
Total stockholders' equity 35,111 49,932
Total liabilities and stockholders' equity $ 53,613 $ 72,890